Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future

OO Ogunleye, D Basu, D Mueller, J Sneddon… - Frontiers in …, 2020 - frontiersin.org
Background The COVID-19 pandemic has already claimed considerable lives. There are
major concerns in Africa due to existing high prevalence rates for both infectious and non …

Policies for biosimilar uptake in Europe: an overview

E Moorkens, AG Vulto, I Huys, P Dylst, B Godman… - PloS one, 2017 - journals.plos.org
Background Across European countries, differences exist in biosimilar policies, leading to
variations in uptake of biosimilars and divergences in savings all over Europe. Objectives …

Drivers of poor medical care

V Saini, S Garcia-Armesto, D Klemperer, V Paris… - The Lancet, 2017 - thelancet.com
The global ubiquity of overuse and underuse of health-care resources and the gravity of
resulting harms necessitate an investigation of drivers to inform potential solutions. We …

Coronavirus disease 2019 (COVID-19) pandemic across Africa: current status of vaccinations and implications for the future

OO Ogunleye, B Godman, JO Fadare, S Mudenda… - Vaccines, 2022 - mdpi.com
The introduction of effective vaccines in December 2020 marked a significant step forward in
the global response to COVID-19. Given concerns with access, acceptability, and hesitancy …

Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future

B Godman, D Basu, Y Pillay, JC Mwita… - Frontiers in …, 2020 - frontiersin.org
Background There has been an appreciable increase in the number of people in Africa with
metabolic syndrome and Type 2 diabetes (T2DM) in recent years as a result of a number of …

What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs

SS Dunne, CP Dunne - BMC medicine, 2015 - Springer
Background Considerable emphasis is presently being placed on usage of generic
medicines by governments focussed on the potential economic benefits associated with …

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle …

B Godman, M Haque, J McKimm… - … medical research and …, 2020 - Taylor & Francis
Introduction: Antibiotics are indispensable to maintaining human health; however, their
overuse has resulted in resistant organisms, increasing morbidity, mortality and costs …

Barriers for access to new medicines: searching for the balance between rising costs and limited budgets

B Godman, A Bucsics, P Vella Bonanno… - Frontiers in Public …, 2018 - frontiersin.org
Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …

Medicine shortages: gaps between countries and global perspectives

A Acosta, EP Vanegas, J Rovira, B Godman… - Frontiers in …, 2019 - frontiersin.org
Introduction: Over the last decade, global health policies and different research areas have
focused on the relevance and impact of medicine shortages. Published studies suggest …

The implementation of managed entry agreements in Central and Eastern Europe: findings and implications

A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó… - …, 2017 - Springer
Abstract Background Managed entry agreements (MEAs) are a set of instruments to facilitate
access to new medicines. This study surveyed the implementation of MEAs in Central and …